Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who
are undergoing radiation therapy to the pelvis. It is not yet known whether octreotide is
effective for diarrhea.
PURPOSE: Randomized phase III trial to determine the effectiveness of octreotide in
preventing diarrhea in patients who are undergoing radiation therapy to the pelvis.